The " 2022 Boao Stem Cell Summit and China Stem Cell Industry Alliance Establishment Conference " was grandly held on November 15 in Qionghai City, Hainan Province. At this conference, Shanghai Dongfang Hospital (Dongfang Hospital Affiliated to Tongji University) and 42 domestic medical institutions, universities, scientific research institutes, enterprises, public institutions, and social groups jointly initiated the establishment of the " China Stem Cell Industry Alliance ".

The China Stem Cell Industry Alliance aims to meet the needs of China's population health and economic and social development, through collaborative innovation and resource integration, to build a seven-in-one innovation platform for stem cells "government, industry, research, research and medical investment" , focusing on the frontiers and hot spots of international stem cell research, making breakthroughs Key scientific issues in stem cell and transformation research, accelerate the clinical transformation and application of stem cell products and derivative products , and boost the development of China's stem cell industry. The advisors of the Alliance Expert Committee are composed of 10 academicians, namely Pei Gang, Chen Xiangmei, Ge Junbo, Lin Dongxin, Chen Yihan, Ning Guang, Luo Qingming, Wu Tangchun, Li Jinsong, and Jiang Baoguo. As of the 14th of this month, the number of the first batch of joining units totaled 180, including 42 sponsoring units and 138 member units.

Chen Yihan , academician of the Chinese Academy of Sciences and president of Dongfang Hospital Affiliated to Tongji University, said: " Cell therapy is one of the important means of biological therapy. In view of the key bottleneck period of the stem cell industry explosion, the application of stem cells to clinics as soon as possible requires 5 "requirements". That is to say, there must be major breakthroughs in basic research; key technologies must be accelerated; clinical research must be fully promoted; cell preparation standards must be unified; start-ups must be vigorously supported. ”

Pei Gang , academician of the Chinese Academy of Sciences and professor of Tongji University , pointed out in his speech: " After macromolecular drugs, the most cutting-edge biomedical field in the world is cell and gene therapy. After more than 20 years of joint efforts, China's basic research on stem cells The field is firmly in the forefront of the world. The blossoming and fruiting of the stem cell business requires the prosperity of the stem cell industry, which is inseparable from the support of the Stem Cell Industry Alliance. The industry cannot do without products, enterprises, and entrepreneurs. The development of the industry requires All parties work together. ”  

Li Jinsong , academician of the Chinese Academy of Sciences and director of the State Key Laboratory of Cell Biology at the Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, agreed: "The transfer and transformation of existing research results related to stem cells and the acceleration of clinical applications require close integration of scientific research institutions, enterprises and hospitals. It is necessary to build bridges and bonds. Therefore, the establishment of the China Stem Cell Industry Alliance is at the right time. Through close exchanges and practical cooperation among members of the alliance, it will greatly promote the research and development and industrialization of stem cell drugs in China . "

Liu Zhongmin , chairman of the expert committee of China Stem Cell Industry Alliance, foreign academician of the Russian Academy of Engineering, professor of Dongfang Hospital Affiliated to Tongji University, and director of Shanghai Stem Cell Clinical Transformation Research Institute, said: " I hope that through the establishment of the Stem Cell Industry Alliance, we can promote the joint efforts of experts in stem cells and related fields. Help the scientific approval mechanism applicable to stem cells and form a stem cell-related technology trading platform. When the time is ripe, promote the establishment of stem cell hospitals and promote the early clinical transformation of stem cell products. ”

This conference will hold 1 main forum and 3 sub-forums focusing on the fields of stem cell foundation and transformation integration , stem cell research and industrial transformation , focusing on new technologies, new achievements and new trends in the field of stem cells. Including 8 academicians from the Chinese Academy of Sciences, the Chinese Academy of Engineering, the European Academy of Sciences, and the Russian Academy of Engineering, more than 60 leaders from Hainan Province, more than 60 heavyweight guests in the field of stem cells, and more than 1,000 representatives from companies in the field of stem cells and industry experts (including online).

(Information source: China Securities Network, Tongda Affiliated Court )